Sei Investments CO Intra Cellular Therapies, Inc. Transaction History

Sei Investments CO

$66.7 Billion
Q1 2024

A detailed history of Sei Investments CO transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Sei Investments CO holds 128,311 shares of ITCI stock, worth $8.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

128,311

Previous 116,823 9.83%

Holding current value

$8.93 Million

Previous $8.37 Million 6.13%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$64.37 - $75.65 $739,482 - $869,067	11,488 Added 9.83%	128,311 $8.88 Million
Q4 2023 Feb 14, 2024	SELL	$46.37 - $73.65 $974,604 - $1.55 Million	-21,018 Reduced 15.25%	116,823 $8.37 Million
Q3 2023 Nov 14, 2023	SELL	$52.09 - $64.1 $635,550 - $782,084	-12,201 Reduced 8.13%	137,841 $7.18 Million
Q2 2023 Aug 11, 2023	SELL	$54.67 - $66.44 $175,818 - $213,671	-3,216 Reduced 2.1%	150,042 $9.5 Million
Q1 2023 May 12, 2023	BUY	$43.8 - $56.99 $672,549 - $875,081	15,355 Added 11.13%	153,258 $8.3 Million

Q4 2022 Feb 10, 2023	SELL	$44.07 - $54.45 $447,002 - $552,286	-10,143 Reduced 6.85%	137,903 $7.3 Million
Q3 2022 Nov 14, 2022	SELL	$42.7 - $59.99 $435,582 - $611,957	-10,201 Reduced 6.45%	148,046 $6.89 Million
Q2 2022 Aug 15, 2022	SELL	$43.0 - $65.64 $1.32 Million - $2.01 Million	-30,673 Reduced 16.24%	158,247 $9.03 Million
Q1 2022 May 13, 2022	BUY	$38.74 - $62.09 $901,518 - $1.44 Million	23,271 Added 14.05%	188,920 $11.6 Million
Q4 2021 Feb 14, 2022	BUY	$35.2 - $53.42 $504,240 - $765,241	14,325 Added 9.47%	165,649 $8.68 Million
Q3 2021 Nov 12, 2021	BUY	$28.72 - $42.49 $3.02 Million - $4.47 Million	105,115 Added 227.48%	151,324 $5.64 Million
Q2 2021 Aug 06, 2021	BUY	$29.3 - $44.5 $842,023 - $1.28 Million	28,738 Added 164.49%	46,209 $1.89 Million
Q1 2021 May 12, 2021	BUY	$30.8 - $39.51 $119,288 - $153,022	3,873 Added 28.48%	17,471 $593,000
Q4 2020 Feb 08, 2021	SELL	$23.34 - $32.22 $301,902 - $416,765	-12,935 Reduced 48.75%	13,598 $432,000
Q3 2020 Nov 06, 2020	BUY	$17.61 - $31.86 $267,865 - $484,622	15,211 Added 134.35%	26,533 $681,000
Q2 2020 Aug 17, 2020	BUY	$14.35 - $26.64 $162,470 - $301,618	11,322 New	11,322 $291,000
Q2 2020 Aug 11, 2020	SELL	$14.35 - $26.64 $163,374 - $303,296	-11,385 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$12.31 - $33.12 $140,149 - $377,071	11,385 New	11,385 $175,000
Q2 2019 Aug 14, 2019	SELL	$10.65 - $14.29 $25,517 - $34,238	-2,396 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$17.33 - $23.4 $41,522 - $56,066	2,396 New	2,396 $42,000

Others Institutions Holding ITCI

# of Institutions

381

Shares Held

77.7M

Call Options Held

1.7M

Put Options Held

1.13M

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $6.57B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Intra Cellular Therapies, Inc. Transaction History